...
首页> 外文期刊>Journal of cardiovascular medicine >Reply: intravenous loop diuretics versus isolated ultrafiltration for chronic congestive heart failure: competition or integration?
【24h】

Reply: intravenous loop diuretics versus isolated ultrafiltration for chronic congestive heart failure: competition or integration?

机译:答复:静脉loop利尿剂与单纯超滤治疗慢性充血性心力衰竭:竞争还是融合?

获取原文
获取原文并翻译 | 示例
           

摘要

The letter by Amico [1] re-proposes a very controversial topic, that is the comparison between intravenous (i.v.) loop diuretic therapy and isolated ultrafiltration in the chronic congestive heart failure (GHF) setting, which may appear an unequal competition at first sight. We are also of the opinion that ultrafiltration only allows the physician to instantaneously adjust the exact dosage of fluids which have to be removed with precision much higher than that attained by simply planning a scheduled course of i.v. loop diuretic therapy [2,3]. Nevertheless, no significant linear correlation has been documented up to now between net fluid removed by ultrafiltration or by diuretics and changes in serum creatinine [4].
机译:Amico [1]的信再次提出了一个很有争议的话题,那就是在慢性充血性心力衰竭(GHF)情况下静脉(iv)loop利尿剂治疗和孤立的超滤之间的比较,乍一看可能会出现不平等的竞争。我们还认为,超滤仅允许医生即时调节必须精确去除的流体剂量,其精确度远高于简单地计划静脉注射的预定过程所达到的精确度。利尿剂治疗[2,3]。然而,迄今为止,在超滤或利尿剂清除的净液与血清肌酐变化之间尚无明显的线性相关性[4]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号